Sun Pharma, with $6.2 billion revenue, released its ESG Overview.

Key highlights: ~21% carbon, 25% water reduction (vs 2020 baseline), 41% renewable energy.

R&D spend 6.2%. Zero Class-I recalls, 4 USFDA observations.

Sales programs drove 15.1% revenue growth; manager program boosted production efficiency by 9%.